Top Markets
Coin of the day
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Rang in Aktien #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
Aktienkurs
$20.65
Zuletzt synchronisiert: 2023-03-01
Marktkapitalisierung
$82.52M
Veränderung (1 Tag)
-0.58%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Opiant Pharmaceuticals, Inc. (OPNT)

Kategorie

Dividendenhistorie für Opiant Pharmaceuticals, Inc. (OPNT)
Opiant Pharmaceuticals, Inc. (Aktienkürzel: OPNT) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Opiant Pharmaceuticals, Inc. (OPNT) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
0.00%
US
0.00%
NL
0.00%
US
64.00%
AU
0.00%
CH